Cargando…

MIR-491: CDKN2A tumor suppressor co-pilot

Detalles Bibliográficos
Autores principales:	Moore, Lynette M., Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671939/ https://www.ncbi.nlm.nih.gov/pubmed/26682264

Ejemplares similares

miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer
por: Lu, Lei, et al.
Publicado: (2019)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
por: Li, Xia, et al.
Publicado: (2014)

JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR-491-5p
por: Li, Yan, et al.
Publicado: (2019)

miR-491-3p functions as a tumor suppressor in non-small cell lung cancer by targeting fibroblast growth factor 5
por: Zhang, Gai, et al.
Publicado: (2022)

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
por: Zhu, Changyu, et al.
Publicado: (2023)

MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway
por: Guo, Jingyun, et al.
Publicado: (2021)

miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN
por: Hu, Yang, et al.
Publicado: (2020)

miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer
por: Sun, Ruifang, et al.
Publicado: (2017)

Ginsenoside Rh2 Suppresses Metastasis and Growth of Colon Cancer via miR-491
por: Wei, Wene, et al.
Publicado: (2021)

491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children
por: Dolan, Susan, et al.
Publicado: (2021)

Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022)

Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells
por: Ding, Hui, et al.
Publicado: (2022)

miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2
por: Chen, Ting, et al.
Publicado: (2018)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury
por: Tang, Wei, et al.
Publicado: (2021)

Tumor suppressor prostaglandin D(2)
por: Maeda, Shingo, et al.
Publicado: (2014)

Urinary Levels of miR-491-5p and miR-592 as Potential Diagnostic Biomarkers in Female Aging Patients with OAB: A Pilot Study
por: Cammisotto, Philippe G., et al.
Publicado: (2022)

miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro
por: Qi, Zengxin, et al.
Publicado: (2016)

Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer
por: Huang, Wei-Chieh, et al.
Publicado: (2021)

CDKN1C/p57(kip2 )is a candidate tumor suppressor gene in human breast cancer
por: Larson, Pamela S, et al.
Publicado: (2008)

Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance
por: Yang, Chenlong, et al.
Publicado: (2020)

miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4
por: Wu, Fuyong, et al.
Publicado: (2021)

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
por: Algar, Elizabeth M., et al.
Publicado: (2009)

THU491 GRHL2 Overexpression In Breast Cancer Progression
por: Zheng, Christy, et al.
Publicado: (2023)

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020)

Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2
por: Xie, Zheng-Yuan, et al.
Publicado: (2018)

SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

491. Aerosol-Generating Medical Procedures: Transmission of SARS-CoV-2 and Emerging Viruses
por: Judson, Seth D, et al.
Publicado: (2020)

MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
por: Zhang, Yajie, et al.
Publicado: (2016)

Downregulation of miR‐491‐5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4
por: Yu, Ting, et al.
Publicado: (2018)

Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors
por: Vladusic, Tomislav, et al.
Publicado: (2010)

Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer
por: Yu, Haiou, et al.
Publicado: (2022)

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis
por: Li, Wentao, et al.
Publicado: (2021)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

491 Outcomes of an Integrated Research Ethics Consultation Service
por: Smith, Elise, et al.
Publicado: (2023)

Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
por: Minervini, Giovanni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o5pc7bgq3kb7ua2m92fhqlgeit